Together we will beat cancer

Donate

‘Levelling Up’: What should it mean for cancer?

The UK Government has set out how they’ll help parts of the country to catch up on a range of measures, including health.

Read More

120 years of discovery: 10 ways we’ve changed the story for people with cancer

From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years.

Read More

11 top tips for cutting back on alcohol

If you’re one of the many people who want to cut back on drinking this January, but aren’t sure where to start, we’ve got you covered.

Read More

Facing the future: “How can a 3-year old understand that her daddy is going to die?”

Becky and Manish both had the heart-breaking job of preparing their own young children for a future without them.

Read More

Prising open the trap: Getting to grips with targeted cancer drug resistance

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

Read More

Cervical screening in Wales extended to every 5 years: Why the switch?

Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.

Read More

Let’s get to the bottom of it – 7 common cancer myths, unpicked

From 5G to sharks with cancer, we want to set the record straight with 7 commonly asked questions about cancer that are often rooted in misinformation.

Read More

The digital shift: How are remote GP appointments affecting cancer patients?

Covid-19 has changed the way we see the GP. While many have embraced remote appointments, others worry they could lead to missed or delayed cancer diagnoses.

Read More

6 of the biggest good news cancer stories of 2021

From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from 2021.

Read More

How will new cancer medicines be approved in the future?

In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?

Read More